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Synaptotagmin-7 is a candidate Ca2 sensor for exocytosis that is at
least partly localized to synapses. Similar to synaptotagmin-1, which
functions as a Ca2 sensor for fast synaptic vesicle (SV) exocytosis,
synaptotagmin-7 contains C2A and C2B domains that exhibit Ca2-
dependent phospholipid binding. However, synaptotagmin-7 cannot
replace synaptotagmin-1 as a Ca2 sensor for fast SV exocytosis,
raising questions about the physiological significance of its Ca2-
binding properties. Here, we examine how synaptotagmin-7 binds
Ca2 and test whether this Ca2 binding regulates Ca2-triggered SV
exocytosis. We show that the synaptotagmin-7 C2A domain exhibits
a Ca2-binding mode similar to that of the synaptotagmin-1 C2A
domain, suggesting that the synaptotagmin-1 and -7 C2 domains
generally employ comparable Ca2-binding mechanisms. We then
generated mutant mice that lack synaptotagmin-7 or contain point
mutations inactivating Ca2 binding either to both C2 domains of
synaptotagmin-7 or only to its C2B domain. Synaptotagmin-7-mutant
mice were viable and fertile. Inactivation of Ca2 binding to both C2
domains caused an 70% reduction in synaptotagmin-7 levels,
whereas inactivation of Ca2 binding to only the C2B domain did not
alter synaptotagmin-7 levels. The synaptotagmin-7 deletion did not
change fast synchronous release, slow asynchronous release, or
short-term synaptic plasticity of release of neurotransmitters. Thus,
our results show that Ca2 binding to the synaptotagmin-7 C2 do-
mains is physiologically important for stabilizing synaptotagmin-7,
but that Ca2 binding by synaptotagmin-7 likely does not regulate SV
exocytosis, consistent with a role for synaptotagmin-7 in other forms
of Ca2-dependent synaptic exocytosis.
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At the synapse, neurotransmitter release is mediated by Ca2-dependent exocytosis of synaptic vesicles (SVs) (1, 2). In
mammals, Ca2 triggers exocytosis by binding to two distinct classes
of Ca2 sensors: synaptotagmin-1, -2, or -9, which mediate fast
synchronous release; and an unknownCa2 sensor, whichmediates
asynchronous release (3–9). A similar situation appears to operate
in Drosophila, except that only a single synaptotagmin isoform
seems to be involved (10, 11).
Synaptotagmins constitute a family of membrane-trafficking
proteins composed of a single transmembrane domain, a variable
linker sequence, and two C2 domains (the C2A and C2B domains)
(reviewed in refs. 12–15). Of 15 synaptotagmins identified in the
mammalian genome, 8 exhibit Ca2-dependent phospholipid bind-
ing (synaptotagmin-1, -2, -3, -5, -6, -7, -9, and -10), and 7 do not (see
references cited in ref. 8). Four synaptotagmins are localized to SVs:
synaptotagmin-1, -2, and -9, which function as Ca2 sensors for fast
exocytosis, and synaptotagmin-12, which does not bind Ca2, but
regulates release (16). The remaining 11 synaptotagmins are prob-
ably present on other types of secretory vesicles and/or the plasma
membrane. In synaptotagmin-1, the C2A and C2B domains bind
two and three Ca2 ions, respectively, via similar Ca2-binding sites
(17–19). Based on their comparable phospholipid-binding proper-
ties and putativeCa2-binding sequences, other synaptotagmins are
thought to bind Ca2 by similar mechanisms. However, this hy-
pothesis has not been directly tested. Sequence analyses can be
misleading, as exemplified by synaptotagmin-4, which was believed
to bind Ca2 based only on sequence analyses (20) until biophysical
studies revealed that it is unable to do so (21). Thus, direct
measurements of Ca2 binding are essential to define whether and
how a particular synaptotagmin binds Ca2.
Among synaptotagmins, synaptotagmin-7 is particularly interest-
ing because it is initially expressed ubiquitously during development
but is later restricted to dividing cells (including immortalized
cancer cells), postmitotic neurons, and neuroendocrine cells (22).
Moreover, synaptotagmin-7 is extensively alternatively spliced in a
developmentally regulated pattern in its linker region connecting
the C2 domains with the membrane (23, 24). Ubiquitous synapto-
tagmin-7 contains only a relatively short alternatively spliced se-
quence, whereas neuronal synaptotagmin-7 exhibits a baroque
variety of alternative splice variants. Ubiquitous synaptotagmin-7 is
present on intracellular organelles and/or the plasma membrane
(22, 25), whereas neuronal synaptotagmin-7 is enriched in synapses,
but is excluded from SVs (23, 26). Finally, synaptotagmin-7 in
neuroendocrine cells is localized to large secretory vesicles (27–29).
Compared with synaptotagmin-1, the C2 domains of synap-
totagmin-7 display a higher apparent Ca2 affinity during
phospholipid binding (30–33), suggesting that synaptotag-
min-7 might function as a Ca2 sensor for exocytosis (30). Four
types of studies were performed to test this hypothesis: (i)
addition of dominant-negative recombinant C2 domain frag-
ments to permeabilized secretory cells (23, 34), (ii) overex-
pression of synaptotagmin-7 in secretory cells or cultured
neurons (26, 29), (iii) suppression of synaptotagmin-7 levels by
RNAi in nonneuronal cells (27–29), and (iv) analysis of
nonneuronal cells from synaptotagmin-7 KO mice (35, 36).
These studies supported a role for synaptotagmin-7 as a Ca2
sensor for exocytosis but produced conf licting results. For
example, in neuroendocrine PC12 cells, recombinant synap-
totagmin-7 C2-domain fragments are potent inhibitors of
Ca2-dependent exocytosis, which also is impaired by RNAi
knockdown of synaptotagmin-7 (23, 27–29). However, these
experiments did not address the puzzling competing observa-
tion that synaptotagmin-9 is the primary Ca2 sensor for
exocytosis in PC12 cells (37, 38). In another example, synap-
totagmin-7 was proposed to act as a Ca2 sensor for lysosome
exocytosis (25, 35). However, an independent study suggested
that synaptotagmin-7 acts as a regulator of lysosomal fusion-
Author contributions: A.M., Y.L., J.R., and T.C.S. designed research; A.M., Y.L., and H.L.
performed research; A.M., X.C., J.R., and T.C.S. analyzed data; and A.M., J.R., J.B.S., and
T.C.S. wrote the paper.
The authors declare no conflict of interest.
§Present address: Department of Cell Biology, The Scripps Research Institute, 10550 North
Torrey Pines, La Jolla, CA 92037.
††To whom correspondence should be addressed. E-mail: thomas.sudhof@utsouthwestern.
edu.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0712372105/DC1.
© 2008 by The National Academy of Sciences of the USA
3986–3991  PNAS  March 11, 2008  vol. 105  no. 10 www.pnas.orgcgidoi10.1073pnas.0712372105
pore expansion and not as an exocytic Ca2 sensor (36).
Indeed, it is puzzling that Ca2-induced lysosome exocytosis
persists in cells lacking synaptotagmin-7. Moreover, synaptic
transmission has not been tested in synaptotagmin-7 KO
neurons despite the fact that neurons contain the highest
synaptotagmin-7 levels in mature mice, although exocytosis
appears to be normal in neuromuscular junctions of f lies that
lack a possible synaptotagmin-7 ortholog (39).
To address the question of whether Ca2 binding to synaptotag-
min-7 plays a role in SV exocytosis, we have now studied the
intrinsic Ca2-binding properties of the synaptotagmin-7 C2A do-
main and examined the physiological importance of Ca2 binding
to the C2A and C2B domain of synaptotagmin-7 in synaptic
exocytosis.We show that the synaptotagmin-7 C2A domain exhibits
Ca2-binding properties that are similar to those of the synapto-
tagmin-1 C2 domains and that inactivation of Ca2 binding to both
C2 domains of synaptotagmin-7 destabilizes the protein in vivo,
whereas inactivation of Ca2 binding to only the C2B domain does
not. Finally, we demonstrate that deletion of synaptotagmin-7 does
not affect spontaneous or evoked inhibitory neurotransmission and
short-term synaptic plasticity in mice despite its dramatic effect on
Ca2-dependent catecholamine release in chromaffin cells (40).
These observations suggest that Ca2 binding to synaptotagmin-7
is physiologically important but does not regulate synaptic
exocytosis.
Results
Ca2-Binding Properties of the Synaptotagmin-7 C2A Domain. Both
C2 domains of synaptotagmin-7 bind to phospholipids as a
function of Ca2, suggesting that they directly bind Ca2 (23, 30,
31). However, only the Ca2-binding mode of a single synapto-
tagmin isoform, synaptotagmin-1, was previously determined
directly. To test whether synaptotagmin-7 binds Ca2 in a mode
similar to that of synaptotagmin-1, we analyzed its C2A domain
by NMR spectroscopy.
Using the purified, uniformly 15N,13C-labeled C2A domain of
synaptotagmin-7, we used standard triple resonance spectra
(HNCACB and CBCACONH) to assign its backbone resonances
(Fig. 1A). We then performed Ca2 titrations monitored by 1H-15N
HSQC spectra to determine its Ca2-binding mode (Fig. 1 B–D) as
described for the synaptotagmin-1 C2A domain (17, 18). The
C2A-domain spectra exhibited excellent cross-peak dispersion,
showing that the domain is folded. Marked Ca2-dependent move-
ments were observed for many 1H-15N HSQC cross-peaks from
residues in the predicted Ca2-binding loops. This behavior was
similar to that observed for the synaptotagmin-1 C2A domain.
Indeed, the locations of many cross-peaks in the spectrum and the
directions of the Ca2-dependent movements were analogous
(examples are the cross-peaks of T170, S171, K194, D227, and S230
of the synaptotagmin-7 C2A domain, which correspond to T176,
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Fig. 2. Strategy for generation of synaptotagmin-7-mutant mouse lines. (A)
Diagram of the synaptotagmin-7 domain structure (Upper: TMR, transmem-
brane region; arrowhead, position of the alternatively spliced linker region)
and sequences of the Ca2-binding sites in the two C2 domains (C2A and C2B)
that were mutated in the knockin (KI) mice (Lower: red boxes, aspartate
residues essential for Ca2 binding; asterisks, aspartate residues replaced with
alanine residues in synaptotagmin-7 knockin mice). (B) Homologous recom-
bination strategy for synaptotagmin-7 C2B- and C2AB-domain mutant mice. A
NEO-resistance gene cassette flanked by LoxP sites (blue triangles) was intro-
duced into an EcoRI site in intron 12, and a diphtheria toxin gene (DT) was
inserted downstream of the short vector arm. The coding sequences of exons
11 and 13 (red boxes) were mutated to replace six aspartate residues that bind
Ca2 in the C2A and C2B domains with alanines (D225, D227, and D233 in exon
11; D303, D357, and D359 in exon 13) (see asterisks in A). Diagrams on the
bottom depict the mutant synaptotagmin-7 alleles containing alanine substi-
tutions in both exon 11 and 13 (C2AB KI/KO) or only in exon 13 (C2B KI/KO) and
the subsequent Cre-recombined alleles in which the NEO cassettes were
excised.
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Fig. 1. Analysis of intrinsic Ca2 binding to the synaptotag-
min-7 C2A domain by NMR spectroscopy. (A) Superposition of
1H-15N HSQC spectra of the 15N-labeled synaptotagmin-7 C2A
domain acquired at Ca2 concentrations of 0–5 mM. The
spectrum obtained in the absence of Ca2 is shown in black;
rainbow coloring was used for the remaining spectra (red,
lowest Ca2 concentrations; blue, highest Ca2 concentra-
tions). Selected cross-peak assignments are indicated (red ar-
rows, Ca2-dependent movement of some cross-peaks). (B–D)
Superpositions of expansions of analogous 1H-15N HSQC spec-
tra acquired in the presence of 0–40 mM Ca2, illustrating the
Ca2-dependent movement of the cross-peaks from D227,
L224, and D225 (other cross-peaks in the expansions that
exhibit little or no Ca2-dependent changes are also labeled).
The Ca2 concentrations used are indicated next to some of
the cross-peaks and in the box below the spectra.








S177, K200, D232, and S235 of the synaptotagmin-1 C2A domain)
(Fig. 1 B–D and data not shown). Clear curved movements were
observed for Ca2 concentrations ranging from 0–800 M for
multiple cross-peaks (e.g., D227 and S230) (Fig. 1). Based on the
similar behavior of the two domains, these curved movements can
be unambiguously attributed to Ca2 binding to the first two of
three Ca2-binding sites (Ca1 and Ca2). The curves are less
pronounced in the synaptotagmin-7 C2A domain than in the
synaptotagmin-1 C2A domain because the Ca2 affinities of the
Ca1 and Ca2 sites are more similar to each other. This fact hinders
the measurement of accurate Kds, allowing only an approximate
estimate of the Ca1 and Ca2 affinities (Ca1 Kd  150 M Ca2
based particularly on the K194 NH cross-peaks that are primarily
affected by Ca2 binding to this site; Ca2 Kd  200–300 M).
At the highest Ca2 concentrations used (2 and 5 mM), we
observed an additional change in the movement direction for a few
cross-peaks (e.g., S171 and D227) (Fig. 1). Analogous to the
synaptotagmin-1 C2A domain (18), this additional component can
be attributed to Ca2 binding to a third site (Ca3) with a very low
affinity. Overall, these data demonstrate that the Ca2-binding
mechanism of the synaptotagmin-7 C2A domain is similar to that of
the synaptotagmin-1 C2A domain, although differences exist in the
intrinsic Ca2-binding affinities as predicted from their distinct
Ca2-dependent phospholipid-binding properties (31). It seems
likely that this conclusion also applies to the C2B domain, and we
thus conclude that the similar sequences and Ca2-dependent
phospholipid-binding properties of the synaptotagmin-1 and -7 C2
domains correlate with similar intrinsic Ca2-binding properties of
these domains.
Generation of Synaptotagmin-7-Mutant Mice. To determine the role
of synaptotagmin-7 in Ca2-dependent exocytosis, we generated
three lines of mutant mice by using a single homologous recombi-
nation experiment (Fig. 2): (i) mice in which expression of synap-
totagmin-7 was abolished, (ii) mice in which Ca2 binding to both
C2 domains was inactivated, and (iii) mice in which Ca2 binding
only to the C2B domain was inactivated.
The initial homologous recombination experiment used a
targeting vector that contained a NEO-resistance cassette in
intron 12 for positive selection, a diphtheria toxin cassette
f lanking the short arm for negative selection, and alanine
substitutions in essential aspartates residues in the C2A- and
C2B-domain Ca2-binding sites to inactivate Ca2 binding
(Fig. 2). After homologous recombination, we identified mu-
tant ES cells that contained the NEO cassette and included
either the mutations in both C2 domains or only in the C2B
domain, with the latter presumably arising from spontaneous
repair of the C2A-domain mutations during homologous re-
combination. We generated mice from these mutant ES cells
and bred them to homozygosity. Quantitative immunoblotting
demonstrated that in mice that were homozygous for the C2B-
or the C2AB-domain knockin and contained the NEO-
resistance cassette, the expression of synaptotogmin-7 was
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Fig. 4. Fast synaptic transmission in neurons lacking synaptotagmin-7. (A)
Representative IPSCs monitored in cortical neurons from littermate WT and
synaptotagmin-7 KO mice cultured 14 days in vitro. IPSCs were recorded in 2 mM
extracellular Ca2 in the presence of AP5 and CNQX. Synaptic responses were
evoked by single action potentials applied at 0.1 Hz (arrows). Scale bars apply to
both traces. (Insets) Initial phases of multiple responses collected from the same
neuron to illustrate the kinetics of the IPSC onset. (B) Average rise times of IPSCs
recorded from WT and synaptotagmin-7-deficient neurons in 10 mM extracellu-
lar Ca2 (meansSDs; WT,n9; KO,n10). (C) Amplitudes and synaptic charge
transfer (integrated over 1.5 s) of individual IPSCs in WT and synaptotagmin-7-
deficient neurons monitored in 2 mM or 10 mM Ca2or 10 mM Sr2 as indicated.
Data are plotted as a fraction of the WT response (means SDs; 2 mM Ca2, WT,
n 9; KO, n 8; 10 mM Ca2, WT, n 14; KO, n 14; 10 mM Sr2, WT, n 12;
KO,n 10; from two to four cultures from littermate WT and KO mice). (D) Time
course of individual IPSCs monitored from WT (solid lines) and synaptagmin-7-
deficientneurons (dashedlines).Plotsexhibit thecumulativechargetransferover
1.5 s after an action potential (means SDs; 2 mM Ca2, WT, n 15; KO, n 9;
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A B C DFig. 3. Expression of synaptotag-min-7 in mutant mice. (A) Repre-
sentative immunoblots of synapto-
tagmin-7 (Syt 7), Rab 3,
synaptotagmin-1 (Syt 1), and syn-
taxin-1A (Syx 1) in brain proteins
(40g per lane) from synaptotag-
min-7 KO and Cre-recombined C2B
and C2AB knockin mice and their
WT littermate controls. Symbols on
the left indicate the four major
brain synaptotagmin-7 splice vari-
ants (S, short form; L, long form).
(B–D) Expression levels of individual synaptotagmin-7 splice variants in the brains of adult (P30) KO (B) and Cre-recombined C2B- and C2AB-domain KI mice (C
and D, respectively) determined by quantitative immunoblotting with 125I-labeled secondary antibodies and normalized to expression in their WT littermates
(means  SDs; n  3).
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to refer to these mice as KO mice. Consistent with a previous
report (35), homozygous synaptotagmin-7 KO mice were
viable and fertile and did not display significant abnormalities
in body weight (data not shown).
To remove the NEO cassette, we crossed the mutant mice to
transgenic mice with germ-line expression of Cre recombinase.
Quantitative immunoblotting showed that excision of the NEO-
resistance cassette fully restored the expression of synaptotagmin-7
when only the C2B-domain Ca2-binding sites were mutated (Fig.
3 A and C). However, excision of the NEO cassette only increased
the expression of synaptotagmin-7 to only 20–30% of WT levels
when both C2 domains were mutated (Fig. 3A andD). Because the
only difference between the two C2B- and the C2AB-domain
knockin lines after excision of the NEO cassette is the presence or
absence of point mutations in the C2A domain (all other intronic
and exonic sequences are identical), the mutation in the C2A-
domain Ca2-binding sites must have destabilized the synaptotag-
min-7 protein.
Synaptic Transmission in Synaptotagmin-7-Deficient Neurons. To
determine whether synaptotagmin-7 is a Ca2 sensor for SV
exocytosis, we performed systematic analyses of GABAergic
synaptic transmission in neurons isolated from synaptotag-
min-7 KO mice and their WT littermates. In this study, we
carried out measurements of GABAergic transmission in
mixed cultured cortical neurons by using focal stimulation
(41). We first analyzed the properties of evoked synaptic
responses triggered by single-action potentials in the presence
of 2 mM Ca2, 10 mM Ca2, or 10 mM Sr2 in the extracellular
bath. We found that under all three experimental conditions
inhibitory postsynaptic currents (IPSCs) monitored from WT
and synaptotagmin-7-deficient neurons displayed similar sizes
and kinetics of onset and decay (Fig. 4), indicating that
deletion of synaptotagmin-7 did not have a significant effect on
fast-evoked SV exocytosis and the Ca2 dependence of re-
lease. In addition, we found that deletion of synaptotgmin-7
did not alter the frequency and amplitudes of miniature IPSC
events (minis), suggesting that synaptotagmin-7 is not involved
in triggering or regulating minis (data not shown).
To probe for a potential role of synaptotagmin-7 in the regulation
of short-term synaptic plasticity, fast SV recycling, and/or asynchro-
nous release, we analyzed the properties of synaptic responses
triggered by trains of 50 action potentials applied at stimulation
frequencies of 5–50 Hz. Again, we found that deletion of synapto-
tagmin-7 did not have a significant effect on charges transferred by
high-frequency inhibitory responses during the stimulus train (train
release) or after the stimulus train (delayed release), suggesting that
both synchronous and asynchronous components of neurotrans-
mitter release were unaffected (Fig. 5 A and B). Consistent with
these observations, WT and synaptotagmin-7-deficient neurons
displayed similar kinetics of synchronous IPSC depression during
action potential trains [supporting information (SI) Fig. 7] and
became increasingly desynchronized during the stimulus train (Fig.
5 C and D).
Together, our data indicate that synaptotagmin-7 is unlikely to
be involved in the regulation of SV exocytosis and probably has
no role in short-term synaptic plasticity. However, it is possible
that synaptotagmin-1 is redundant with synaptotagmin-7 in
asynchronous but not synchronous release. To examine this
possibility, we crossed synaptotagmin-7 and synaptotagmin-1
KO mice with each other and analyzed cortical cultures from
mice that lack synaptotagmin-7 and either express or lack
synaptotagmin-1. These experiments demonstrated that the ro-
bust asynchronous release present in synaptotagmin-1 KO neu-
rons (42) is not impaired by the additional deletion of synapto-
tagmin-7, providing further support for the conclusion that
synaptotagmin-7 is not involved in this process (Fig. 6).
Discussion
In this study, we employ biophysical, genetic, and electrophysio-
logical analyses to test the general role of synaptotagmin-7 in the
regulation of neurotransmitter release and the specific hypothesis
that it functions as a Ca2 sensor for asynchronous release. We
demonstrate that Ca2 binding to the synaptotagmin-7C2Adomain
operates by a similar mechanism as Ca2 binding to the synapto-
tagmin-1 C2A domain, confirming that these molecules are struc-
turally similar.We show that, consistent with a previous report (35),
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Fig. 5. Properties of inhibitory synaptic responses
triggered by trains of action potentials. (A) Represen-
tative IPSCs recorded from WT and synaptotagmin-7-
deficient neurons during a 5-Hz, 10-s action potential
train in 2 mM extracellular Ca2. Arrows indicate the
areas defined as train release (TR, release during the
stimulus train) and delayed release (DR, tail currents
observed after the end of the stimulus train). Scale bars
apply to both traces. (B) Average synaptic charge
transfer induced by stimulus trains of 50 action poten-
tials applied at 5–50 Hz in WT and synaptotagmin-7-
deficient neurons during the train (train release), after
the train (delayed release), and over the entire exper-
iment (total charge transfer) plotted as a function of
the stimulation frequency. IPSCs were triggered in 10
mM extracellular Ca2 (means  SDs; WT, n  14; KO,
n 12). (C) Examples of individual IPSCs elicited by 50
action potentials applied at 20 Hz in WT and synapto-
tagmin-7 KO neurons. In the examples, aligned and
normalized IPSCs from the beginning (solid lines, IPSCs
2–5) and end of the stimulus train (dashed lines, IPSCs
47–50) are depicted. (D) Rise times of IPSCs during a
train of 50 action potentials applied at 20 Hz, plotted
as a function of stimulus number. Rise times were
normalized to the first response (data represent indi-
vidual points from three different neurons).








do not display significant abnormalities in body weight. Moreover,
we find that mutations in synaptotagmin-7 that prevent Ca2
binding to either one or both of its C2 domains also do not affect
its viability or fertility. We observe, however, that inactivation of
Ca2 binding to both synaptotagmin-7 C2 domains destabilizes the
protein, whereas inactivation of Ca2 binding to only the C2B
domain does not. Please note that the destabilization of synapto-
tagmin-7 by the Ca2-binding site mutations is not a simple
reflection of a functional inactivation because, at least in chromaffin
cells, inactivation of Ca2 binding to the C2B domain alone impairs
the function of synatotagmin-7 as a Ca2 sensor for exocytosis (40).
Please also note that the inactivating mutations we introduced into
the C2A and C2B domains are single amino acid substitutions that
are unlikely to have an effect on the folding of the C2 domains, but
that we cannot completely rule out a misfolding effect at elevated
physiological temperatures.
The fact that inactivation of Ca2 binding to synaptotagmin-7
destabilizes the protein suggests that synaptotagmin-7 physiologi-
cally functions as a Ca2-binding protein and validates its candidacy
as a Ca2-sensor protein. To test whether this putative function
operates in SV exocytosis, we examined the effect of the deletion
of synaptotagmin-7 on neurotransmitter release. Surprisingly, we
found in inhibitory neurons that synaptotagmin-7 is not essential for
triggering synchronous or asynchronous release or for regulating
presynaptic short-term plasticity. This conclusion is based on the
observations that synaptotagmin-7-deficient neurons display nor-
mal synaptic responses triggered by single-action potentials, a
normal Ca2 dependence of release, and an unchanged amount of
release induced by high-frequency stimulus trains. In particular, the
magnitude and kinetics of synaptic responses triggered by the
stimulus train and of delayed release that correspond to a form of
asynchronous release were not altered by the synaptotagmin-7
deletion, indicating that synaptotagmin-7 is not involved in trigger-
ing asynchronous release, the regulation of the size of readily
releasable pool of SVs, or the speed of SV recycling. The absence
of an effect of the synaptotagmin-7 deletion on SV exocytosis is
especially notable in view of the essential role of synaptotagmin-7
in chromaffin cell exocytosis (40).
Neurons display two distinct modes of neurotransmitter release
that are driven by distinct Ca2 sensors: fast synchronous and slow
asynchronous release (4, 5, 9, 43–46). Three synaptotagmins that
are differentially expressed in the brain, synaptotagmin-1, -2, and -9,
function as Ca2 sensors for fast synchronous SV exocytosis (3–9).
In contrast, the molecular nature of a slow asynchronous Ca2
sensor remains elusive despite extensive electrophysiological anal-
yses in various synapse preparations (42–46). Because of its unique
biochemical properties and partially synaptic localization, synapto-
tagmin-7 was proposed as a candidate for such a Ca2 sensor (30),
but our observations argue against this possibility. Indeed, we show
that WT and synaptotagmin-7-deficient neurons display similar
magnitudes of delayed asynchronous release triggered by high-
frequency trains and similar kinetics of IPSC desynchronization
during train stimulation, suggesting that asynchronous release
operates normally in the absence of synaptotagmin-7. Our conclu-
sions are in agreementwith the functional characterization of a slow
Ca2 sensor in Calyx ofHeld synapses, which suggests that the Ca2
cooperativity of an asynchronous sensor is inconsistent with the
intrinsic Ca2-binding properties of synaptotagmin-7 (9). As re-
vealed by Schonn et al. (40), deletion of synaptotagmin-7 or
inactivation of Ca2 binding to the synaptotagmin-7 C2B domain
indeed impairs Ca2-induced chromaffin granule exocytosis in
chromaffin cells, supporting the role of synaptotagmin-7 as a Ca2
sensor for dense-core vesicle exocytosis. Similarly, the studies by
Gustavsson et al. (47) demonstrated that synaptotagmin-7 is essen-
tial for normal insulin exocytosis in pancreatic -cells. On the
background of a lack of an effect of the same mutations on SV
exocytosis, these observations suggest that, in neurons, synaptotag-
min-7 may be involved in the control of synaptic neuropeptide
release or some other form of Ca2-induced exocytosis, a hypoth-
esis that needs to be further elucidated before it can be accepted.
Methods
NMR spectroscopy was performed essentially as described previously (17, 18) by
using uniformly 15N,13C-labeled recombinant proteins. For a detailed description
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Fig. 6. Synaptotagmin-7 deletion does not suppress asynchro-
nous release in synaptotagmin-1-deficient neurons. (A and B)
Normalized amplitudes (A) and charges (B) of IPSCs triggered by
isolated action potentials in WT neurons (n  24) or neurons
lacking synaptotagmin-1 (Syt 1KO,n20), synaptotagmin-7 (Syt
7 KO, n 14), or both synaptotagmin-1 and -7 (Syt 1/7 DKO, n
10). In addition, neurons lacking synaptotagmin-1 and -7 were
infected with lentivirus encoding the short splice variant of
synaptotagmin-7 to test rescue (Syt 1/7 DKO Syt 7, n 3). Note
that the ns apply to all panels of this figure; data are from two
independent cultures, with the rescue experiment performed
for one of the two cultures. (C) Time course of single IPSCs
triggered by isolated action potentials in WT neurons or neurons
lacking synaptotagmin-1 (Syt 1 KO), synaptotagmin-7 (Syt 7 KO),
synaptotagmin-1 and -7 (Syt 1/7 DKO), or Syt 1/7 DKO neurons
infected with the lentivirus encoding the short synaptotagmin-7
splice variant (Syt 1/7 DKO  Syt 7). The time course is depicted
as a cumulative plot of the synaptic charge transfer. (D and E)
Representative traces (D) and mean synaptic charge transfer
(normalized to that observed in synaptotagmin-7-deficient neu-
rons) of inhibitory responses triggered by high-frequency action
potential trains in synaptotagmin-7 KO and in synaptotagmin-1
and -7 double KO neurons. (F) Contribution of delayed asynchro-
nous release to total synaptic charge transfer in WT neurons and
neurons lacking synaptotagmin-1 alone or both synaptotag-
min-1 and -7. IPSCs were triggered by trains of 2–50 action
potentials applied at 10 Hz. The charges of delayed responses are
represented as a fraction of total response and plotted as a
function of the stimulus number. Data shown in all panels are
means  SDs.
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Generation of Synaptotagmin-7-Mutant Mice. We produced mutant synapto-
tagmin-7 mice containing the C2A- and C2B-domain mutations or only the C2B-
domain mutations and the NEO cassette by homologous recombination (see Fig.
2) essentially as described previously (6). For in vivo NEO-cassette excision, the
heterozygous offspring of chimera/C57B/6 parents were crossed to a transgenic
line expressing Cre recombinase.
Neuronal Cultures and Electrophysiology. Analyses of inhibitory synaptic trans-
mission in cultured cortical neurons were performed as described previously (41,
42). All data are shown are means SDs or SEMs as indicated. Statistical signif-
icance was assessed by Student’s t test.
Miscellaneous Procedures. SDS/PAGE electrophoresis and quantitative immu-
noblotting were performed by using standard procedures.
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